US Patent Issued to Quanterix on Feb. 3 for "Methods of assaying phosphorylated tau protein in a sample" (Swedish, American Inventors)

ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,540,950, issued on Feb. 3, was assigned to Quanterix Corp. (Billerica, Mass.).

"Methods of assaying phosphorylated tau protein in a sample" was invented by David Wilson (Boxborough, Mass.), John Henrik Zetterberg (Molnlycke, Sweden), Kaj Blennow (Kungsbacka, Sweden) and Jeffrey D. Randall (Canton, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention, in some embodiments, generally relates to methods of determining a treatment protocol for and/or a prognosis of a patient's recovery from a brain injury. In some embodiments, the brain injury results from a hypoxic event. In some embodiments, methods are provided for determining a measu...